Effects of medicinal plants and natural compounds in models of prostate cancer related to sex steroids: A systematic review
Authors:
- Rafael Abe da Rocha MirandaRMRafael Abe da Rocha Miranda
- Maria Isadora Gabriel SampaioMSMaria Isadora Gabriel Sampaio
- João Victor Dutra GomesJoão Victor Dutra Gomes
- Damaris SilveiraDamaris Silveira
- Eliete Neves Silva GuerraEGEliete Neves Silva Guerra
- Adriana Lofrano‐PortoALAdriana Lofrano‐Porto
- Cinthia Gabriel MeirelesCMCinthia Gabriel Meireles
- Luiz Alberto SimeoniLSLuiz Alberto Simeoni
- 23 May 2022
- journal article
- review article
- Published by Wiley in Phytotherapy Research
- Vol. 36 (8) , 3032-3079
Abstract
Prostate cancer remains a health problem for men. Targeting androgen (AR) and estrogen (ER) receptors improves the outcomes of the disease, and many medicinal plants exert their effects by modulating these pathways. Therefore, a systematic review was conducted to identify medicinal plants and their natural compounds that may modulate the AR and/or ER pathways in cell and animal models. A search was conducted across EMBASE, LILACS, PubMed, Scopus, and Web of Science, with grey literature from Google SCHOLAR and ProQuest. Two authors independently selected eligible studies based on their titles and abstracts, and a third author resolved conflicts. Then, data from the full text of eligible studies were extracted and synthesized. In total, 75 studies were included. Results showed the effects of several different medicinal plants and natural compounds in reduction of AR and/or ER transcription and translation and AR secondary effects: cell growth reduction, induction of apoptosis, and cell cycle arrest. In animal models, tumor size reduction, increase in apoptosis, and downregulation of AR expression in tumors were also observed. No single phytochemical group concentrating molecules with anti‐AR and/or ER activity was identified. Nevertheless, several phytochemical compounds showed potential for future clinical studies in the management of the disease.Keywords
This publication has 91 references indexed in Scilit:
- Cryptotanshinone suppresses androgen receptor-mediated growth in androgen dependent and castration resistant prostate cancer cellsCancer Letters, 2012
- Kava Components Down-Regulate Expression of AR and AR Splice Variants and Reduce Growth in Patient-Derived Prostate Cancer Xenografts in MicePLOS ONE, 2012
- Anti-cancer effects of novel flavonoid vicenin-2 as a single agent and in synergistic combination with docetaxel in prostate cancerBiochemical Pharmacology, 2011
- Galbanic acid decreases androgen receptor abundance and signaling and induces G1 arrest in prostate cancer cellsInternational Journal of Cancer, 2011
- Andrographolide Targets Androgen Receptor Pathway in Castration-Resistant Prostate CancerGenes & Cancer, 2011
- An international registry of systematic-review protocolsThe Lancet, 2011
- Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell linesHuman Molecular Genetics, 2010
- Transcriptional Repression and Inhibition of Nuclear Translocation of Androgen Receptor by Diallyl Trisulfide in Human Prostate Cancer CellsClinical Cancer Research, 2009
- Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletionNature Reviews Endocrinology, 2009
- Pomegranate polyphenols down-regulate expression of androgen-synthesizing genes in human prostate cancer cells overexpressing the androgen receptorThe Journal of Nutritional Biochemistry, 2008